Polyclonal Antibodies
Anti-DLX5 Polyclonal Antibody for WB, ELISA - P56178
Item Number : CM0013656
Price varies based on specs and customizations
- Application
- WB, ELISA
- Cross Reactivity
- Human, Mouse, Rat
- Protein Weight
- 32kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | DLX5 Rabbit pAb |
| Remarks/Alias | SHFM1; SHFM1D; DLX5 |
| Species | Human |
| GeneID (human) | 1749 |
| GeneID | 1749 |
| Immunogen | Synthetic peptide corresponding to a sequence within amino acids 200 to the C-terminus of human DLX5 (NP_005212.1) |
| Source | Rabbit |
| Category | Polyclonal Antibodies |
| Application | WB, ELISA |
| Cross Reactivity | Human, Mouse, Rat |
| SWISS | P56178 |
| Protein Weight | 32kDa |
| Shipping | Ice bag |
Biological Background: DLX5 Function and Localization
- DLX5 is a homeobox-containing transcription factor that plays a crucial role in bone development by acting as an immediate early BMP-responsive activator essential for osteoblast differentiation.
- It stimulates the promoter activity of ALPL (alkaline phosphatase) and SP7 (osterix) in a RUNX2-independent manner, driving the transcriptional program of bone-forming cells.
- DLX5 binds to specific homeodomain-response elements in target gene promoters, with the consensus DNA-binding sequence 5'-TAATTA-3'.
- It localizes to the nucleus, consistent with its function as a transcriptional regulator.
- Keywords from UniProt include: Alternative splicing, Deafness, Developmental protein, Disease variant, DNA-binding, Homeobox, Nucleus, Osteogenesis, Phosphoprotein, and Transcription regulation, highlighting its multifunctional role in development and disease.
- DLX5 is also implicated in cell proliferation through up-regulation of MYC promoter activity.
Experimental Guidance and Technical Tips
- The immunogen is a synthetic peptide corresponding to the C-terminal region (amino acids 200 to end) of human DLX5, so the antibody may recognize full-length protein and potentially some isoforms.
- For Western blot, consider using osteoblast-like cell lines (e.g., Saos-2, MG-63) or bone tissue lysates where DLX5 expression is expected; endogenous levels may be low in non-osseous tissues.
- Cross-reactivity with mouse and rat has been reported; validate species-specific performance in your experimental system using appropriate controls.
- In ELISA applications, optimize coating conditions and antibody dilutions based on the peptide immunogen to ensure sensitivity and specificity.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio offers a streamlined procurement channel for IVD manufacturers and research laboratories seeking high-quality raw materials. This anti-DLX5 polyclonal antibody supports bone development and transcription factor research, available alongside validated antibody pairs, bulk ancillary reagents, and custom sourcing for rare targets. We help you bridge concept-to-clinic with reliable, science-backed sourcing solutions.
Product Datasheet
Anti-DLX5 Polyclonal Antibody for WB, ELISA - P56178
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!